Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Retrotope, Inc

+1 (650) 209-5007
Website

Advertisement

Advertisement

4300 El Camino Real Ste 201
Los Altos, CA 94022
+1 (650) 209-5007
https://www.retrotope.com

Retrotope, Inc is a biotechnology company based in Los Altos, CA that focuses on developing novel therapies for neurodegenerative diseases.

Specializing in targeting lipid peroxidation, Retrotope, Inc is dedicated to advancing innovative treatments to address unmet medical needs in the field of neurology.

Generated from their business information

Also at this address

youngQi Clinic

Electric - EDF Innovation Lab Inc

David Berman, MD

Berman Skin Institute

yelp logo
77 reviews

EDF Sa

Own this business?
Claim it
See a problem?

You might also like

Business services, nec, nec, Eating places

Exelixis, Inc

Exelixis is an integrated drug discovery and development company. The company utilizes cutting-edge genomic, molecular biology and combinatorial chemistry technologies to develop innovative therapies for significant human diseases. Its primary mission is to improve patient care by developing proprietary human therapeutics that target the complex molecular causes of disease. Exelixis has built a research and discovery platform. The Exelixis clinical development pipeline includes compounds in cancer and renal disease. The company s pre-clinical pipeline is comprised of six programs. The pre-clinical oncology programs consist of development candidates that focus on inhibiting kinases. In its pre-clinical metabolic disease programs, Exelixis has developed small molecules that modulate nuclear hormone receptors that implicate various metabolic and cardiovascular disorders. Corporate headquarters are in San Francisco. The research facility is in Portland, Ore.
Business services, nec, nec, Medical research, commercial

Prolynx, LLC

ProLynx Inc is a San Francisco-based company specializing in advanced technology products and solutions. With a dedicated team of experienced professionals, the company offers a range of innovative products, including the PLX038 Pipeline, designed to meet the needs of various industries. Driven by a strong management board and supported by a team of advisors, ProLynx Inc is at the forefront of technological advancements, delivering cutting-edge solutions to its clients. Committed to research and development, the company continues to make significant contributions to the industry, ensuring its position as a leader in the field.Generated from the website
Avg Technologies
Business services, nec, nec, Custom computer programming services, Art gallery

Avg Technologies

Dynavax Technologies Corporation was founded in August 1996. The company discovers, develops and intends to commercialize products to treat and prevent allergies, infectious diseases and chronic inflammatory diseases, using proprietary approaches that alter immune system responses in specific ways. Its clinical development programs are based on immunostimulatory sequences, or ISS, which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation. Dynavax s pipeline includes: TOLAMBA, a ragweed allergy immunotherapeutic, which has completed a large-scale Phase 2/3 clinical trial, and is in a supportive clinical trial in ragweed allergic children; HEPLISAV, a hepatitis B vaccine that is in a pivotal Phase 3 clinical trial; a cancer therapy in a Phase 2 clinical trial; and an asthma immunotherapeutic that has shown preliminary safety and pharmacologic activity in a Phase 2a clinical trial.
United States›California›Los Altos›Retrotope, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell